Rilonacept

Ended Awarded Last action

Contract number
36C26023F0017
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 -$210,068
Original award $210,068

About this award

Kiniksa Pharmaceuticals (UK) LTD has been awarded a delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration for the pharmaceutical Rilonacept. With a potential value of $0.00 and a completion date of September 30, 2023, this firm fixed price contract calls for Kiniksa to provide the drug to support healthcare programs under VISN 20. No set-aside designation was applied to this award issued from the GSA Schedule. Place of performance will be in Great Britain.

Quick answers

Who was awarded contract 36C26023F0017?

36C26023F0017 was awarded to Kiniksa Pharmaceuticals (Uk), LTD. by Veterans Integrated Service Network 20 (Veterans Health Administration) on October 1, 2022.

How much is contract 36C26023F0017 worth?

The government has obligated $0 on 36C26023F0017.

Is contract 36C26023F0017 an order under another contract?

Yes. 36C26023F0017 is a delivery order under 36F79722D0002, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26023F0017 competed?

The extent of competition for 36C26023F0017 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award